You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. INTERACTIVE TECHNOLOGIES TO MODIFY CANCER RISK BEHAVIORS

    SBC: ABACUS HEALTH SOLUTIONS, LLC            Topic: N/A

    DESCRIPTION (provided by applicant)The major goals of this revised, SBIR Phase II application for the combined R25/R44 mechanism to complete development of a multi-media, cancer risk behavior modification intervention and to conduct a randomized controlled trial with low income patients and their primary care physicians to assess its impact. The prototype system of tools created in the Phase I is ...

    SBIR Phase II 2002 Department of Health and Human ServicesNational Institutes of Health
  2. INTERACTIVE TECHNOLOGIES TO MODIFY CANCER RISK BEHAVIORS

    SBC: ABACUS HEALTH SOLUTIONS, LLC            Topic: N/A

    DESCRIPTION (provided by applicant)The major goals of this revised, SBIR Phase II application for the combined R25/R44 mechanism to complete development of a multi-media, cancer risk behavior modification intervention and to conduct a randomized controlled trial with low income patients and their primary care physicians to assess its impact. The prototype system of tools created in the Phase I is ...

    SBIR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health
  3. ANTIVIRAL SCREENING AGAINST MULTIPLE VIRUSES

    SBC: APATH, LLC            Topic: N/A

    DESCRIPTION (Provided by applicant): Although cell-based screening has been used successfully throughout the drug-discovery field, it is problematic when screening for antiviral compounds. This is because it requires inoculation of infectious virus onto the cells and the production of additional infectious progeny virus. Handling such infectious material is not easi ...

    SBIR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health
  4. INDICATOR CELLS FOR ANTIVIRAL SCREENING FOR FILOVIRUSES

    SBC: APATH, LLC            Topic: N/A

    DESCRIPTION (provided by applicant): The goal of this proposal is to develop the commercial potential of a cell-based assay to screen for compounds with antiviral activity against filoviruses such as Ebola and Marburg viruses. The basis of this bioassay, which has been prototyped with respiratory syncytial virus, is infection-independent expression of a reporter gene from an artificial viral genom ...

    SBIR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health
  5. ANTIVIRAL SCREENING ASSAYS BASED ON HCV REPLICONS

    SBC: APATH, LLC            Topic: N/A

    DESCRIPTION (Provided by applicant): Hepatitis C virus (HCV) is the most prevalent chronic blood-borne infection in the U.S and a global health problem. Approximately 4 million individuals in the U.S. and 170 million individuals worldwide are chronically infected. As much as 40 percent of chronic liver disease is HCV related and this results in up to 10,000 deaths each year. Despite improvements, ...

    SBIR Phase II 2002 Department of Health and Human ServicesNational Institutes of Health
  6. ANTIVIRAL SCREENING ASSAYS BASED ON HCV REPLICONS

    SBC: APATH, LLC            Topic: N/A

    DESCRIPTION (Provided by applicant): Hepatitis C virus (HCV) is the most prevalent chronic blood-borne infection in the U.S and a global health problem. Approximately 4 million individuals in the U.S. and 170 million individuals worldwide are chronically infected. As much as 40 percent of chronic liver disease is HCV related and this results in up to 10,000 deaths each year. Despite improvements, ...

    SBIR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health
  7. ElectronicTextile Antennas

    SBC: Applied Radar, Inc.            Topic: N/A

    "Current man portable antennas are heavy, rigid, telescoping or umbrella like contraptions, which limit the mobility and speed of a deployed unit. We propose to improve the weight, storage size, and ease of deployment of a portable antenna through the useof electronic textiles as described in this proposal. Planar antennas have been manufactured on thin films and rolled into position, however a ri ...

    SBIR Phase I 2002 Department of DefenseDefense Advanced Research Projects Agency
  8. DEVICE FOR MEMORY DYSFUNCTION

    SBC: ARIZONA INSTITUTE FOR BIO-MEDICAL RES            Topic: N/A

    Forgetfulness or memory dysfunction occurs more frequently with advancing age, as well as in situations of routine office environments. Routine office tasks like filing are frequently boring tasks, and the forgetfulness problem is exacerbated when an individual with a proclivity to memory dysfunction is working with time constraints and large volumes of materials. We propose to develop a computer ...

    SBIR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health
  9. DEVICE FOR MEMORY DYSFUNCTION

    SBC: ARIZONA INSTITUTE FOR BIO-MEDICAL RES            Topic: N/A

    Forgetfulness or memory dysfunction occurs more frequently with advancing age, as well as in situations of routine office environments. Routine office tasks like filing are frequently boring tasks, and the forgetfulness problem is exacerbated when an individual with a proclivity to memory dysfunction is working with time constraints and large volumes of materials. We propose to develop a computer ...

    SBIR Phase II 2002 Department of Health and Human ServicesNational Institutes of Health
  10. DEVELOPMENT OF A VASOACTIVE BIOGEL

    SBC: Azerx, Inc.            Topic: N/A

    DESCRIPTION (provided by applicant): Cardiovascular disease is the leading cause of death in the United States and other developed countries. The treatment of cardiovascular disease often involves surgically bypassing occluded segments of blood vessels with human saphenous vein grafts. Approximately 1,000,000 aortocoronary and peripheral revascularizations are performed using human saphenous vein ...

    STTR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government